🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

BMO raises DuPont stock price target, maintains Outperform rating

EditorNatashya Angelica
Published 01/08/2024, 14:24
DD
-

On Thursday, BMO Capital Markets adjusted its outlook on shares of DuPont de Nemours Inc (NYSE:DD), increasing the stock's price target from $96.00 to $100.00. The firm maintained an Outperform rating on the chemical conglomerate.

The revision reflects a positive view of the company's end markets, particularly in the electronics sector, where DuPont is benefiting from higher utilization rates and greater chip complexity.

The analyst from BMO Capital indicated that DuPont's Water & Protection (W&P) segment is experiencing a moderation of its previous headwinds. Moreover, there is an expectation that if interest rate cuts occur, the Shelter segment could see a significant uptick in 2025.

These factors, combined with rising earnings, robust free cash flow (FCF) conversion, and encouraging updates on perfluorooctanoic acid (PFOA) litigation, contribute to the optimism surrounding DuPont's stock performance.

DuPont's potential split, which has been a subject of interest for investors, also plays a role in the positive assessment. The company's progress toward this strategic move is seen as a catalyst that could propel the stock toward the newly set $100 price target over the next 12 months.

The Outperform rating is reiterated based on the company's strong fundamentals and favorable market conditions. BMO Capital's revised price target suggests confidence in DuPont's ability to leverage its market position and financial health to deliver value to shareholders in the foreseeable future.

In other recent news, DuPont de Nemours Inc has reported a 17% increase in operating EBITDA for the second quarter of 2024, surpassing its previous guidance. This growth is credited to advancements in technology applications, including AI, and a recovery in the consumer electronics market. Furthermore, DuPont has acquired medical device manufacturer Donatelle, strengthening its position in this sector.

BMO Capital Markets recently increased DuPont's price target from $96.00 to $100.00, maintaining an Outperform rating. This adjustment reflects the firm's positive outlook on DuPont's end markets, especially in the electronics sector. BMO Capital also pointed out that DuPont's Water & Protection segment is experiencing a moderation of its previous headwinds.

In other developments, DuPont is progressing with its planned separation, with executive and board appointments expected to finalize in early 2025. The company's potential split is viewed as a catalyst that could drive the stock toward the newly set $100 price target.

Finally, DuPont has raised its full-year guidance for net sales, operating EBITDA, and adjusted EPS, indicating confidence in continued growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.